ENTRY       D02163                      Drug
NAME        Fluphenazine maleate (JAN);
            Flumezin (TN)
FORMULA     C22H26F3N3OS. C4H4O4
EXACT_MASS  553.1858
MOL_WEIGHT  553.5937
CLASS       Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG03200  Antipsychotic agent
              DG01905  Phenothiazine antipsychotics
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      Therapeutic category: 1172
            ATC code: N05AB02
            Chemical structure group: DG00874
            Product (DG00874): D00791<US> D00793<JP/US> D02163<JP>
EFFICACY    Antipsychotic, Dopamine D2 receptor antagonist
COMMENT     Phenothiazine derivative
TARGET      DRD2 [HSA:1813] [KO:K04145]
  PATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07029  Antipsychotics - phenothiazines
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AB Phenothiazines with piperazine structure
                 N05AB02 Fluphenazine
                  D02163  Fluphenazine maleate (JAN) &lt;JP&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              1st Generation/Typical
               Fluphenazine
                D02163  Fluphenazine maleate (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1172  Phenothiazines
                 D02163  Fluphenazine maleate (JAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00874  Fluphenazine
                 D02163  Fluphenazine maleate
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00874  Fluphenazine
                 D02163  Fluphenazine maleate
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00874  Fluphenazine
                D02163  Fluphenazine maleate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D02163  Fluphenazine maleate (JAN) &lt;JP&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02163
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00874  Fluphenazine
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00874  Fluphenazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00874  Fluphenazine
DBLINKS     CAS: 78126-11-1
            PubChem: 7849224
            LigandBox: D02163
ATOM        38
            1   C8y C    16.7464  -19.7213
            2   N1y N    17.9613  -19.0204
            3   C8y C    16.7464  -21.1232
            4   C8x C    15.5315  -19.0204
            5   C8y C    19.2230  -19.7213
            6   C1b C    17.9613  -17.6186
            7   S2x S    17.9613  -21.7773
            8   C8x C    15.5315  -21.7773
            9   C8x C    14.3633  -19.7213
            10  C8y C    19.2230  -21.0764
            11  C8x C    20.4380  -19.0204
            12  C1b C    19.2230  -16.9177
            13  C8x C    14.3633  -21.0764
            14  C8x C    20.4380  -21.7773
            15  C8y C    21.6529  -19.7681
            16  C1b C    19.2230  -15.4690
            17  C8x C    21.6529  -21.0764
            18  N1y N    20.4380  -14.7681
            19  C1x C    20.4380  -13.4130
            20  C1x C    21.6062  -15.4690
            21  C1x C    21.6529  -12.7121
            22  C1x C    22.8678  -14.7681
            23  N1y N    22.8678  -13.4130
            24  C1b C    24.1295  -12.7588
            25  C1b C    25.3321  -13.4901
            26  O1a O    26.5577  -12.8192
            27  C1d C    22.8691  -19.0883
            28  X   F    24.0800  -18.4100
            29  X   F    23.5900  -20.3000
            30  X   F    22.1900  -17.9200
            31  C2b C    32.7051  -16.3098
            32  C2b C    31.0687  -16.3098
            33  C6a C    33.3596  -17.4786
            34  C6a C    30.4143  -17.4786
            35  O6a O    32.7051  -18.6475
            36  O6a O    34.7622  -17.4786
            37  O6a O    29.0117  -17.4786
            38  O6a O    31.0687  -18.6475
BOND        40
            1    18  19 1
            2    18  20 1
            3    19  21 1
            4    20  22 1
            5    21  23 1
            6    23  24 1
            7     7  10 1
            8     9  13 1
            9    15  17 1
            10   22  23 1
            11    1   2 1
            12    1   3 2
            13    1   4 1
            14    2   5 1
            15    2   6 1
            16    3   7 1
            17    3   8 1
            18    4   9 2
            19    5  10 2
            20    5  11 1
            21    6  12 1
            22    8  13 2
            23   10  14 1
            24   11  15 2
            25   12  16 1
            26   14  17 2
            27   16  18 1
            28   24  25 1
            29   25  26 1
            30   15  27 1
            31   27  28 1
            32   27  29 1
            33   27  30 1
            34   31  32 2
            35   31  33 1
            36   32  34 1
            37   33  35 1
            38   33  36 2
            39   34  37 1
            40   34  38 2
///
